Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Padagis Hit With Immediate Suit After Filing First ANDA For US Zoryve Cream
ANDA Approval Likely Delayed Beyond October 2026; Padagis Eyes 180-Day Exclusivity
Apr 04 2024
•
By
Dean Rudge
• Source: Shutterstock
More from Generics
More from Products